SCNI

#5161
Scinai Immunotherapeutics Ltd. American Depositary Shares
0.6021 USD
+1.81%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
0.6021
0.6021
Rango anual
0.5500
1.0499
Cambio diario
+1.81%
Variación mensual
-13.89%
Variación en los últimos 6 meses
-20.38%
Cambio anual
-20.38%
Cierres anteriores
0.5914
Abrir
0.6021
Bid
Ask
Mínimo
0.6021
High
0.6021
Volumen
1
Ver el calendario completo

Financials

Visión general Informes Estadísticas
Trimestre Año
  • Market Capitalization 2.0882 M
  • Employee 45
  • Founded 2003
  • CEO N/A
  • Website www.scinai.com
  • Headquarter Israel
  • FIGI BBG007TGL1R2
  • Industry Biotecnología
Ingresos totales
Beneficio neto
Deuda total
Flujo de caja libre
Efectivo y equivalentes

Scinai Immunotherapeutics Ltd - American Depositary Shares

BiondVax Pharmaceuticals Ltd. is an Israeli biopharmaceutical company focused on developing and manufacturing immunotherapeutic products, primarily for the treatment of infectious diseases and autoimmune diseases. In collaboration with the Max Planck Institute for Multidisciplinary Sciences and the University Medical Center Göttingen, both in Germany, BiondVax develops nanosized antibody therapies for diseases such as COVID-19, asthma and psoriasis.

Noticias